Utility of routinely acquired primary care data for paediatric disease epidemiology and pharmacoepidemiology

British Journal of Clinical Pharmacology

Volumn 59, Issue 6, 2005, Pages 684-690

  Helms, Peter J ^a,b   Daukes, Suzie Ekins ^a   Taylor, Michael W ^a   Simpson, Colin R ^a   McLay, James S ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ROYAL ABERDEEN CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Children; Medicines; Prescribing disease epidemiology; Primary care

Indexed keywords

ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; CORTICOSTEROID; PARACETAMOL;

ADOLESCENT; ARTICLE; ASTHMA; CHILD; CHILDHOOD DISEASE; DIAGNOSTIC VALUE; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG FORMULATION; FEMALE; HUMAN; MALE; MORBIDITY; NATIONAL HEALTH SERVICE; NEWBORN; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; UNITED KINGDOM;

ADOLESCENT; AGE DISTRIBUTION; ASTHMA; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; DRUG APPROVAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; PEDIATRICS; PHARMACOEPIDEMIOLOGY; PRESCRIPTIONS, DRUG; PRIMARY HEALTH CARE; REPRODUCIBILITY OF RESULTS; SCOTLAND; STATE MEDICINE;

EID: 20644442237     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2005.02404.x     Document Type: Article

References (31)

1. Straand J, Rokstad K, Heggedal U. Drug prescribing for children in general practice. A report from the More & Romsdal Prescription Study. Acta Paediatr 1998; 87 (2): 218-24.
2. Rylance GW, Woods CG, Cullen RE, Rylance ME. Use of drugs by children. BMJ 1988; 297 (6646): 445-7.
3. Schirm EBP, Gebben H, Sauer P, De Jong-van den Berg. Drug use of children in the community assessed through pharmacy dispensing data. Br J Clin Pharmacol 2000; 50 (5): 473-8.
4. Thrane N, Sorensen HT. A one-year population-based study of drug prescriptions for Danish children. Acta Paediatr 1999; 88 (10): 1131-6.
5. Cazzato T, Pandolfini C, Campi R, Bonati M. Drug prescribing in out-patient children in Southern Italy. Eur J Clin Pharmacol 2001; 57 (8): 611-6.
6. Madsen H, Andersen M, Hallas J. Drug prescribing among Danish children: a population-based study. Eur J Clin Pharmacol 2001; 57 (2): 159-65.
7. McIntyre J, Conroy S, Avery A, Corns H, Choonara I. Unlicensed and off-label prescribing of drugs in general practice. Arch Dis Child 2000; 83 (6): 498-501.
8. Ekins-Daukes S, Helms PJ, Simpson CR, Taylor MW, McLay JS. Off-label prescribing to children in primary care: retrospective observational study. Eur J Clin Pharmacol 2004, 1991-92; 60: 349-53.
9. McCormick A, Fleming D, Charlton J. Morbidity Statistics from General Practice - Fourth National Study. London: HMSO, 1995
10. Mann RD, Taylor MW, MacDonald TM, Jick H, Rawlins MD, Wood SM, Walter PC, Fletcher P. Databases for pharmacovigilance. What can we do? MBRF, 1996.
11. Lawrenson R, Williams T, Farmer R. Clinical information for research; the use of general practice databases. J Public Health Med 1999; 21 (3): 299-304.
12. Walley T, Mantgani A. The UK General Practice Research Database Lancet 1997; 350 (9084): 1097-9.
13. Garcia Rodriguez LA, Perez GS. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 1998; 45 (5): 419-25.
14. Lawrenson RA, Coles G, Walton K, Farmer RDT. Characteristics of practices contributing to the MediPlus database and the implications for its use in epidemiological research. Journal of Informatics in Primary Care 1998: May: 14-18.
15. Simpson CR, Anderson WJ, Helms PJ, Taylor MW, Watson L, Prescott GJ, Godden DJ, Barker RN. Coincidence of immune-mediated diseases driven by Th1 and Th2 subsets suggests a common aetiology. A population-based study using computerized general practice data. Clin Exp Allergy 2002; 32: 37-42.
16. Saint_Yves IF. The read clinical classification. Health Bull (Edinb) 1992; 50 (6): 422-7.
17. Hansell A, Hollowell JNT, McNiece R, Strachan D. Use of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th Morbidity Survey in General Practice (MSGP4). Thorax 1999; 54: 413-9.
18. About GPASS. http://www.gpass.co.uk (accessed 03/2005).
19. The primary clinical information unit, university of Aberdeen, http://www.abdn.ac.uk/general_practice/research/special/pcclu-r/index.shtml (accessed 03/2005).
20. Ryan MP. A system for general practice computing in Scotland. Health Bull (Edinb) 1989; 47 (3): 110-9.
21. Milne RM, Taylor MW, Duncan R. An assessment of computing activity by GPASS users in Scottish general practice. Health Bull (Edinb) 1991; 49 (2): 152-60.
22. Whitelaw FG, Nevin SL, Milne RM, Taylor RJ, Taylor MW, Watt AH. Completeness and accuracy of morbidity and repeat prescribing records held on general practice computers in Scotland. Br J General Pract 1996; 46 (404): 181-6.
23. Association of the British Pharmaceutical Industry (ABP). Compendium of Data Sheets and Summaries of Product Characteristics. Datapharm Publications Limited, Epsom, Surrey, UK 1999.
24. British Medical Association Royal Pharmaceutical Society of Great Britain. British National Formulary, London 2000: 40 edn.
25. Wieringa MH, Weyler JJ, Van Bever HP, Nelen VJ, Vermeire PA. Gender differences in respiratory, nasal and skin symptoms: 6-7 versus 13-14-year-old children. Acta Paediatr 1999; 88: 147-9.
26. Osman M. Therapeutic implications of sex differences in asthma and atopy. Arch. Dis. Child 2003.
27. 't Jong GW, Eland IA, Sturkenboom MC, van den Anker JN, Stricker BH. Unlicensed and off-label prescription of drugs to children: population based cohort study. BMJ 2002; 324 (7349): 1313-4.
28. 't Jong GW, Eland IA, de Hoog M, Sturkenboom MC, van den Anker JN, Stricker BH. Unlicensed and off-label prescription of systemic anti-infective agents to children. Paediatric Perinatal Drug Ther 2002; 5 (2): 68-74.
29. The British Guidelines on Asthma Management. 1995 review and position statement. Thorax 1997; 52: S1-S21.
30. The British Guidelines on the Management of Asthma. Thorax 2003; 58(Suppl 1): i1-94.
31. Horen B, Montastruc JL, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol 2002; 54 (6): 665-70.